Skip to main content
SpringerLink
Log in

Mouse Models for FXTAS and the Fragile X Premutation

  • Chapter
  • First Online:
Book cover FXTAS, FXPOI, and Other Premutation Disorders

  • 321 Accesses

Abstract

The use of model organisms is essential in order to understand the pathogenesis of many types of human disease, and this is particularly true for the study of genetic diseases such as fragile X syndrome and fragile X-associated tremor/ataxia syndrome (FXTAS). In reverse genetics, the functional study of a gene starts with the question of how a possible phenotype may derive from a specific genetic sequence (disease-causing mutation in a gene). As a first step, a gene function is purposefully altered and the effect on the normal development and/or behavior of the model organism is analyzed. In addition to providing knowledge about the cellular and molecular mechanisms underlying specific genes and their functions, animal models of human disease also provide systems for developing and validating therapeutic strategies.

The choice of which animal model is most suitable to mimic a particular disease depends on a range of factors, including anatomical, physiological, and pathological similarity; presence of orthologs of genes of interest; and conservation of basic cell biological and metabolic processes. In this chapter, we will discuss two model organisms, a mammalian vertebrate (mouse) and an invertebrate model (fly), which have been generated to study the pathogenesis of FXTAS and the effects of potential therapeutic interventions. Both mouse and fly models have proven invaluable for the study of the pathophysiology of FXTAS, including insights into the role of mutant mRNA in this disease (i.e., RNA gain-of-function mechanisms, see Chap. 6).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Allen EG, He W, Yadav-Shah M, Sherman SL (2004) A study of the distributional characteristics of FMR1 transcript levels in 238 individuals. Hum Genet 114(5):439–447

    Article  CAS  PubMed  Google Scholar 

  • Bacalman S, Farzin F, Bourgeois JA, Cogswell J, Goodlin-Jones BL, Gane LW, Grigsby J, Leehey MA, Tassone F, Hagerman RJ (2006) Psychiatric phenotype of the fragile X-associated tremor/ataxia syndrome (FXTAS) in males: newly described fronto-subcortical dementia. J Clin Psychiatry 67(1):87–94

    Article  PubMed  Google Scholar 

  • Bergink S, Severijnen LA, Wijgers N, Sugasawa K, Yousaf H, Kros JM, Van Swieten J, Oostra BA, Hoeijmakers JH, Vermeulen W, Willemsen R (2006) The DNA repair-ubiquitin-associated HR23 proteins are constituents of neuronal inclusions in specific neurodegenerative disorders without hampering DNA repair. Neurobiol Dis 23(3):708–716

    Article  CAS  PubMed  Google Scholar 

  • Bilen J, Bonini NM (2005) Drosophila as a model for human neurodegenerative disease. Annu Rev Genet 39:153–171

    Article  CAS  PubMed  Google Scholar 

  • Bontekoe CJM, Degraaff E, Nieuwenhuizen IM, Willemsen R, Oostra BA (1997) FMR1 premutation allele (CGG)(81) is stable in mice. Eur J Hum Genet 5(5):293–298

    CAS  PubMed  Google Scholar 

  • Bontekoe CJ, Bakker CE, Nieuwenhuizen IM, Van Der Linde H, Lans H, De Lange D, Hirst MC, Oostra BA (2001) Instability of a (CGG)98 repeat in the Fmr1 promoter. Hum Mol Genet 10(16):1693–1699

    Article  CAS  PubMed  Google Scholar 

  • Borthwell RM, Hunsaker MR, Willemsen R, Berman RF (2012) Spatiotemporal processing deficits in female CGG KI mice modeling the fragile X premutation. Behav Brain Res 233(1):29–34

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bourgeois JA, Cogswell JB, Hessl D, Zhang L, Ono MY, Tassone F, Farzin F, Brunberg JA, Grigsby J, Hagerman RJ (2007) Cognitive, anxiety and mood disorders in the fragile X-associated tremor/ataxia syndrome. Gen Hosp Psychiatry 29(4):349–356

    Article  PubMed  PubMed Central  Google Scholar 

  • Braff DL, Geyer MA, Swerdlow NR (2001) Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 156(2–3):234–258

    Article  CAS  Google Scholar 

  • Brouwer JR, Mientjes EJ, Bakker CE, Nieuwenhuizen IM, Severijnen LA, Van Der Linde HC, Nelson DL, Oostra BA, Willemsen R (2007) Elevated Fmr1 mRNA levels and reduced protein expression in a mouse model with an unmethylated Fragile X full mutation. Exp Cell Res 313(2):244–253

    Article  CAS  PubMed  Google Scholar 

  • Brouwer JR, Huizer K, Severijnen LA, Hukema RK, Berman RF, Oostra BA, Willemsen R (2008a) CGG-repeat length and neuropathological and molecular correlates in a mouse model for fragile X-associated tremor/ataxia syndrome. J Neurochem 107(6):1671–1682

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Brouwer JR, Severijnen E, De Jong FH, Hessl D, Hagerman RJ, Oostra BA, Willemsen R (2008b) Altered hypothalamus-pituitary-adrenal gland axis regulation in the expanded CGG-repeat mouse model for fragile X-associated tremor/ataxia syndrome. Psychoneuroendocrinology 33(6):863–873

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Careaga M, Rose D, Tassone F, Berman RF, Hagerman R, Ashwood P (2014) Immune dysregulation as a cause of autoinflammation in fragile X premutation carriers: link between FMRI CGG repeat number and decreased cytokine responses. Plos One 9(4):e94475

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chan HY, Warrick JM, Andriola I, Merry D, Bonini NM (2002) Genetic modulation of polyglutamine toxicity by protein conjugation pathways in Drosophila. Hum Mol Genet 11(23):2895–2904

    Article  CAS  PubMed  Google Scholar 

  • Chen Y, Tassone F, Berman RF, Hagerman PJ, Hagerman RJ, Willemsen R, Pessah IN (2010) Murine hippocampal neurons expressing Fmr1 gene premutations show early developmental deficits and late degeneration. Hum Mol Genet 19(1):196–208

    Article  CAS  PubMed  Google Scholar 

  • Coffey SM, Cook K, Tartaglia N, Tassone F, Nguyen DV, Pan R, Bronsky HE, Yuhas J, Borodyanskaya M, Grigsby J, Doerflinger M, Hagerman PJ, Hagerman RJ (2008) Expanded clinical phenotype of women with the FMR1 premutation. Am J Med Genet A 146A(8):1009–1016

    Article  PubMed  PubMed Central  Google Scholar 

  • Cornish KM, Li L, Kogan CS, Jacquemont S, Turk J, Dalton A, Hagerman RJ, Hagerman PJ (2008) Age-dependent cognitive changes in carriers of the fragile X syndrome. Cortex 44(6):628–636

    Article  PubMed  Google Scholar 

  • Cummings CJ, Sun Y, Opal P, Antalffy B, Mestril R, Orr HT, Dillmann WH, Zoghbi HY (2001) Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. Hum Mol Genet 10(14):1511–1518

    Article  CAS  PubMed  Google Scholar 

  • De Fougerolles A, Vornlocher HP, Maraganore J, Lieberman J (2007) Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov 6(6):443–453

    Article  CAS  PubMed  Google Scholar 

  • Diep AA, Hunsaker MR, Kwock R, Kim K, Willemsen R, Berman RF (2012) Female CGG knock-in mice modeling the fragile X premutation are impaired on a skilled forelimb reaching task. Neurobiol Learn Mem 97(2):229–234

    Article  CAS  PubMed  Google Scholar 

  • Entezam A, Usdin K (2008) ATR protects the genome against CGG.CCG-repeat expansion in Fragile X premutation mice. Nucleic Acids Res 36(3):1050–1056

    Article  CAS  PubMed  Google Scholar 

  • Entezam A, Biacsi R, Orrison B, Saha T, Hoffman GE, Grabczyk E, Nussbaum RL, Usdin K (2007) Regional FMRP deficits and large repeat expansions into the full mutation range in a new Fragile X premutation mouse model. Gene 395(1):125–134

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fernandez-Funez P, Nino-Rosales ML, De Gouyon B, She WC, Luchak JM, Martinez P, Turiegano E, Benito J, Capovilla M, Skinner PJ, Mccall A, Canal I, Orr HT, Zoghbi HY, Botas J (2000) Identification of genes that modify ataxin-1-induced neurodegeneration. Nature 408(6808):101–106

    Article  CAS  PubMed  Google Scholar 

  • Galloway JN, Shaw C, Yu P, Parghi D, Poidevin M, Jin P, Nelson DL (2014) CGG repeats in RNA modulate expression of TDP-43 in mouse and fly models of fragile X tremor ataxia syndrome. Hum Mol Genet 23(22):5906–5915

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Greco CM (2002) Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain 125(8):1760–1771

    Article  CAS  PubMed  Google Scholar 

  • Greco CM, Berman RF, Martin RM, Tassone F, Schwartz PH, Chang A, Trapp BD, Iwahashi C, Brunberg J, Grigsby J, Hessl D, Becker EJ, Papazian J, Leehey MA, Hagerman RJ, Hagerman PJ (2006) Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain 129(Pt 1):243–255

    CAS  PubMed  Google Scholar 

  • Greco CM, Soontrapornchai K, Wirojanan J, Gould JE, Hagerman PJ, Hagerman RJ (2007) Testicular and pituitary inclusion formation in fragile X associated tremor/ataxia syndrome. J Urol 177(4):1434–1437

    Article  CAS  PubMed  Google Scholar 

  • Grigsby J, Brega AG, Engle K, Leehey MA, Hagerman RJ, Tassone F, Hessl D, Hagerman PJ, Cogswell JB, Bennett RE, Cook K, Hall DA, Bounds LS, Paulich MJ, Reynolds A (2008) Cognitive profile of fragile X premutation carriers with and without fragile X-associated tremor/ataxia syndrome. Neuropsychology 22(1):48–60

    Article  PubMed  Google Scholar 

  • Hagerman PJ, Hagerman RJ (2004) Fragile X-associated tremor/ataxia syndrome (FXTAS). Ment Retard Dev Disabil Res Rev 10(1):25–30

    Article  PubMed  Google Scholar 

  • Hagerman RJ, Leehey M, Heinrichs W, Tassone F, Wilson R, Hills J, Grigsby J, Gage B, Hagerman PJ (2001) Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 57(1):127–130

    Article  CAS  PubMed  Google Scholar 

  • Handa V, Saha T, Usdin K (2003) The fragile X syndrome repeats form RNA hairpins that do not activate the interferon‐inducible protein kinase, PKR, but are cut by Dicer. Nucleic Acids Res 31(21):6243–6248

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hashem V, Galloway JN, Mori M, Willemsen R, Oostra BA, Paylor R, Nelson DL (2009) Ectopic expression of CGG containing mRNA is neurotoxic in mammals. Hum Mol Genet 18(13):2443–2451

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • He F, Krans A, Freibaum BD, Taylor JP, Todd PK (2014) TDP-43 suppresses CGG repeat-induced neurotoxicity through interactions with HnRNP A2/B1. Hum Mol Genet 23(19):5036–5051

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hessl D, Tassone F, Loesch DZ, Berry-Kravis E, Leehey MA, Gane LW, Barbato I, Rice C, Gould E, Hall DA, Grigsby J, Wegelin JA, Harris S, Lewin F, Weinberg D, Hagerman PJ, Hagerman RJ (2005) Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation. Am J Med Genet B Neuropsychiatr Genet 139B(1):115–121

    Article  CAS  PubMed  Google Scholar 

  • Hessl D, Rivera S, Koldewyn K, Cordeiro L, Adams J, Tassone F, Hagerman PJ, Hagerman RJ (2007) Amygdala dysfunction in men with the fragile X premutation. Brain 130(Pt 2):404–416

    Article  PubMed  Google Scholar 

  • Hukema RK, Buijsen RA, Raske C, Severijnen LA, Nieuwenhuizen-Bakker I, Minneboo M, Maas A, De Crom R, Kros JM, Hagerman PJ, Berman RF, Willemsen R (2014) Induced expression of expanded CGG RNA causes mitochondrial dysfunction in vivo. Cell Cycle 13(16):2600–2608

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hukema RK, Buijsen RA, Schonewille M, Raske C, Severijnen LA, Nieuwenhuizen-Bakker I, Verhagen RF, Van Dessel L, Maas A, Charlet-Berguerand N, De Zeeuw CI, Hagerman PJ, Berman RF, Willemsen R (2015) Reversibility of neuropathology and motor deficits in an inducible mouse model for FXTAS. Hum Mol Genet 24(17):4948–4957

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hunsaker MR, Wenzel HJ, Willemsen R, Berman RF (2009) Progressive spatial processing deficits in a mouse model of the fragile X premutation. Behav Neurosci 123(6):1315–1324

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hunsaker MR, Goodrich-Hunsaker NJ, Willemsen R, Berman RF (2010) Temporal ordering deficits in female CGG KI mice heterozygous for the fragile X premutation. Behav Brain Res 213(2):263–268

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hunsaker MR, Von Leden RE, Ta BT, Goodrich-Hunsaker NJ, Arque G, Kim K, Willemsen R, Berman RF (2011) Motor deficits on a ladder rung task in male and female adolescent and adult CGG knock-in mice. Behav Brain Res 222(1):117–121

    Article  PubMed  PubMed Central  Google Scholar 

  • Hunsaker MR, Kim K, Willemsen R, Berman RF (2012) CGG trinucleotide repeat length modulates neural plasticity and spatiotemporal processing in a mouse model of the fragile X premutation. Hippocampus 22(12):2260–2275

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hunter JE, Allen EG, Abramowitz A, Rusin M, Leslie M, Novak G, Hamilton D, Shubeck L, Charen K, Sherman SL (2008) Investigation of phenotypes associated with mood and anxiety among male and female fragile X premutation carriers. Behav Genet 38(5):493–502

    Article  PubMed  PubMed Central  Google Scholar 

  • Iwahashi CK, Yasui DH, An HJ, Greco CM, Tassone F, Nannen K, Babineau B, Lebrilla CB, Hagerman RJ, Hagerman PJ (2006) Protein composition of the intranuclear inclusions of FXTAS. Brain 129(Pt 1):256–271

    CAS  PubMed  Google Scholar 

  • Iyer RR, Pluciennik A, Rosche WA, Sinden RR, Wells RD (2000) DNA polymerase III proofreading mutants enhance the expansion and deletion of triplet repeat sequences in Escherichia coli. J Biol Chem 275(3):2174–2184

    Article  CAS  PubMed  Google Scholar 

  • Jacquemont S, Farzin F, Hall D, Leehey M, Tassone F, Gane L, Zhang L, Grigsby J, Jardini T, Lewin F, Berry-Kravis E, Hagerman PJ, Hagerman RJ (2004) Aging in individuals with the FMR1 mutation. Am J Ment Retard 109(2):154–164

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jakupciak JP, Wells RD (1999) Genetic instabilities in (CTG.CAG) repeats occur by recombination. J Biol Chem 274(33):23468–23479

    Article  CAS  PubMed  Google Scholar 

  • Jin P, Warren ST (2003) New insights into fragile X syndrome: from molecules to neurobehaviors. Trends Biochem Sci 28(3):152–158

    Article  CAS  PubMed  Google Scholar 

  • Jin P, Zarnescu DC, Zhang F, Pearson CE, Lucchesi JC, Moses K, Warren ST (2003) RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila. Neuron 39(5):739–747

    Article  CAS  PubMed  Google Scholar 

  • Jin P, Duan R, Qurashi A, Qin Y, Tian D, Rosser TC, Liu H, Feng Y, Warren ST (2007) Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome. Neuron 55(4):556–564

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kazemi-Esfarjani P, Benzer S (2000) Genetic suppression of polyglutamine toxicity in Drosophila. Science 287(5459):1837–1840

    Article  CAS  PubMed  Google Scholar 

  • Kenneson A, Zhang FP, Hagedorn CH, Warren ST (2001) Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum Mol Genet 10(14):1449–1454

    Article  CAS  PubMed  Google Scholar 

  • Khalili K, Del Valle L, Muralidharan V, Gault WJ, Darbinian N, Otte J, Meier E, Johnson EM, Daniel DC, Kinoshita Y, Amini S, Gordon J (2003) Pur alpha is essential for postnatal brain development and developmentally coupled cellular proliferation as revealed by genetic inactivation in the mouse. Mol Cell Biol 23(19):6857–6875

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Krol J, Fiszer A, Mykowska A, Sobczak K, De Mezer M, Krzyzosiak WJ (2007) Ribonuclease dicer cleaves triplet repeat hairpins into shorter repeats that silence specific targets. Mol Cell 25(4):575–586

    Article  CAS  PubMed  Google Scholar 

  • Ladd PD, Smith LE, Rabaia NA, Moore JM, Georges SA, Hansen RS, Hagerman RJ, Tassone F, Tapscott SJ, Filippova GN (2007) An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals. Hum Mol Genet 16(24):3174–3187

    Article  CAS  PubMed  Google Scholar 

  • Lavedan CN, Garrett L, Nussbaum RL (1997) Trinucleotide repeats (CGG)22TGG(CGG)43TGG(CGG)21 from the fragile X gene remain stable in transgenic mice. Hum Genet 100(3–4):407–414

    Article  CAS  PubMed  Google Scholar 

  • Lavedan C, Grabczyk E, Usdin K, Nussbaum RL (1998) Long uninterrupted CGG repeats within the first exon of the human FMR1 gene are not intrinsically unstable in transgenic mice. Genomics 50(2):229–240

    Article  CAS  PubMed  Google Scholar 

  • Lin Y, Tang C, He H, Duan R (2013) Activation of mTOR ameliorates fragile X premutation rCGG repeat-mediated neurodegeneration. PLoS One 8(4):e62572

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lokanga RA, Senejani AG, Sweasy JB, Usdin K (2015) Heterozygosity for a hypomorphic Polbeta mutation reduces the expansion frequency in a mouse model of the Fragile X-related disorders. PLoS Genet 11(4):e1005181

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Louis E, Moskowitz C, Friez M, Amaya M, Vonsattel JP (2006) Parkinsonism, dysautonomia, and intranuclear inclusions in a fragile X carrier: a clinical-pathological study. Mov Disord 21(3):420–425

    Article  PubMed  Google Scholar 

  • Ludwig AL, Espinal GM, Pretto DI, Jamal AL, Arque G, Tassone F, Berman RF, Hagerman PJ (2014) CNS expression of murine fragile X protein (FMRP) as a function of CGG-repeat size. Hum Mol Genet 23(12):3228–3238

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mackay IR, Leskovsek NV, Rose NR (2010) The odd couple: a fresh look at autoimmunity and immunodeficiency. J Autoimmun 35(3):199–205

    Article  CAS  PubMed  Google Scholar 

  • Marek D, Papin S, Ellefsen K, Niederhauser J, Isidor N, Ransijn A, Poupon L, Spertini F, Pantaleo G, Bergmann S, Beckmann JS, Jacquemont S, Tanackovic G (2012) Carriers of the fragile X mental retardation 1 (FMR1) premutation allele present with increased levels of cytokine IL-10. J Neuroinflammation 9:238

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Peier AM, Nelson DL (2002) Instability of a premutation-sized CGG repeat in FMR1 YAC transgenic mice. Genomics 80(4):423–432

    Article  CAS  PubMed  Google Scholar 

  • Primerano B, Tassone F, Hagerman RJ, Hagerman P, Amaldi F, Bagni C (2002) Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations. RNA 8(12):1482–1488

    CAS  PubMed  PubMed Central  Google Scholar 

  • Qurashi A, Liu H, Ray L, Nelson DL, Duan R, Jin P (2012) Chemical screen reveals small molecules suppressing fragile X premutation rCGG repeat-mediated neurodegeneration in Drosophila. Hum Mol Genet 21(9):2068–2075

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Renoux AJ, Sala-Hamrick KJ, Carducci NM, Frazer M, Halsey KE, Sutton MA, Dolan DF, Murphy GG, Todd PK (2014) Impaired sensorimotor gating in Fmr1 knock out and Fragile X premutation model mice. Behav Brain Res 267:42–45

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Samaraweera SE, O’keefe LV, Price GR, Venter DJ, Richards RI (2013) Distinct roles for Toll and autophagy pathways in double-stranded RNA toxicity in a Drosophila model of expanded repeat neurodegenerative diseases. Hum Mol Genet 22(14):2811–2819

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schneider A, Ballinger E, Chavez A, Tassone F, Hagerman RJ, Hessl D (2012) Prepulse inhibition in patients with fragile X-associated tremor ataxia syndrome. Neurobiol Aging 33(6):1045–1053

    Article  PubMed  Google Scholar 

  • Sellier C, Rau F, Liu Y, Tassone F, Hukema RK, Gattoni R, Schneider A, Richard S, Willemsen R, Elliott DJ, Hagerman PJ, Charlet-Berguerand N (2010) Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients. EMBO J 29(7):1248–1261

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sellier C, Freyermuth F, Tabet R, Tran T, He F, Ruffenach F, Alunni V, Moine H, Thibault C, Page A, Tassone F, Willemsen R, Disney MD, Hagerman PJ, Todd PK, Charlet-Berguerand N (2013) Sequestration of DROSHA and DGCR8 by expanded CGG RNA repeats alters microRNA processing in fragile X-associated tremor/ataxia syndrome. Cell Rep 3(3):869–880

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sleasman J (1996) The association between immunodeficiency and the development of autoimmune disease. Adv Dent Res 10(1):57–61

    Article  CAS  PubMed  Google Scholar 

  • Sofola OA, Jin P, Botas J, Nelson DL (2007a) Argonaute-2-dependent rescue of a Drosophila model of FXTAS by FRAXE premutation repeat. Hum Mol Genet 16(19):2326–2332

    Article  CAS  PubMed  Google Scholar 

  • Sofola OA, Jin P, Qin Y, Duan R, Liu H, De Haro M, Nelson DL, Botas J (2007b) RNA-binding proteins hnRNP A2/B1 and CUGBP1 suppress fragile X CGG premutation repeat-induced neurodegeneration in a Drosophila model of FXTAS. Neuron 55(4):565–571

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tan H, Qurashi A, Poidevin M, Nelson DL, Li H, Jin P (2012) Retrotransposon activation contributes to fragile X premutation rCGG-mediated neurodegeneration. Hum Mol Genet 21(1):57–65

    Article  CAS  PubMed  Google Scholar 

  • Tassone F, Hagerman RJ, Taylor AK, Gane LW, Godfrey TE, Hagerman PJ (2000) Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet 66(1):6–15

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tassone F, Hagerman RJ, Garcia-Arocena D, Khandjian EW, Greco CM, Hagerman PJ (2004) Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor/ataxia syndrome. J Med Genet 41(4):e43

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Todd PK, Oh SY, Krans A, Pandey UB, Di Prospero NA, Min KT, Taylor JP, Paulson HL (2010) Histone deacetylases suppress CGG repeat-induced neurodegeneration via transcriptional silencing in models of fragile X tremor ataxia syndrome. PLoS Genet 6(12):e1001240

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Todd PK, Oh SY, Krans A, He F, Sellier C, Frazer M, Renoux AJ, Chen KC, Scaglione KM, Basrur V, Elenitoba-Johnson K, Vonsattel JP, Louis ED, Sutton MA, Taylor JP, Mills RE, Charlet-Berguerand N, Paulson HL (2013) CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome. Neuron 78(3):440–455

    Article  CAS  PubMed  Google Scholar 

  • Van Dam D, Errijgers V, Kooy RF, Willemsen R, Mientjes E, Oostra BA, De Deyn PP (2005) Cognitive decline, neuromotor and behavioural disturbances in a mouse model for fragile-X-associated tremor/ataxia syndrome (FXTAS). Behav Brain Res 162(2):233–239

    Article  CAS  PubMed  Google Scholar 

  • Von Leden RE, Curley LC, Greenberg GD, Hunsaker MR, Willemsen R, Berman RF (2014) Reduced activity-dependent protein levels in a mouse model of the fragile X premutation. Neurobiol Learn Mem 109:160–168

    Article  CAS  Google Scholar 

  • Warrick JM, Paulson HL, Gray-Board GL, Bui QT, Fischbeck KH, Pittman RN, Bonini NM (1998) Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell 93(6):939–949

    Article  CAS  PubMed  Google Scholar 

  • Wenzel HJ, Hunsaker MR, Greco CM, Willemsen R, Berman RF (2010) Ubiquitin-positive intranuclear inclusions in neuronal and glial cells in a mouse model of the fragile X premutation. Brain Res 1318:155–166

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • White PJ, Borts RH, Hirst MC (1999) Stability of the human fragile X (CGG)(n) triplet repeat array in Saccharomyces cerevisiae deficient in aspects of DNA metabolism. Mol Cell Biol 19(8):5675–5684

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Willemsen R, Hoogeveen-Westerveld M, Reis S, Holstege J, Severijnen LA, Nieuwenhuizen IM, Schrier M, Van Unen L, Tassone F, Hoogeveen AT, Hagerman PJ, Mientjes EJ, Oostra BA (2003) The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome. Hum Mol Genet 12(9):949–959

    Article  CAS  PubMed  Google Scholar 

  • Winarni TI, Chonchaiya W, Sumekar TA, Ashwood P, Morales GM, Tassone F, Nguyen DV, Faradz SMH, Van De Water J, Cook K, Hamlin A, Mu Y, Hagerman PJ, Hagerman RJ (2012) Immune-mediated disorders among women carriers of fragile X premutation alleles. Am J Med Genet A 158A(10):2473–2481

    Article  CAS  PubMed  Google Scholar 

  • Zhao XN, Usdin K (2015) The transcription-coupled repair protein ERCC6/CSB also protects against repeat expansion in a mouse model of the fragile X premutation. Hum Mutat 36(4):482–487

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurological Surgery, University of California, Davis, CA, USA

    Molly M. Foote & Robert F. Berman

  2. Department of Psychiatry and Behavioral Sciences, University of California, Davis, CA, USA

    Milo Careaga

  3. Department of Clinical Genetics, Erasmus MC, Rotterdam, The Netherlands

    Ronald A. M. Buijsen, Rob Willemsen & Renate K. Hukema

Authors
  1. Molly M. Foote
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Milo Careaga
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ronald A. M. Buijsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Robert F. Berman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rob Willemsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Renate K. Hukema
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Molly M. Foote .

Editor information

Editors and Affiliations

  1. Department of Biochemistry and Molecular Medicine, University of California, Davis, California, USA

    Flora Tassone

  2. Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA

    Deborah A. Hall

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Foote, M.M., Careaga, M., Buijsen, R.A.M., Berman, R.F., Willemsen, R., Hukema, R.K. (2016). Mouse Models for FXTAS and the Fragile X Premutation. In: Tassone, F., Hall, D. (eds) FXTAS, FXPOI, and Other Premutation Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-33898-9_8

Download citation

Publish with us

Policies and ethics

Search

Navigation